Charles E. Chalfant

University of Virginia

NIH Rank #7385
  • Program Leader
  • R01 Holder
  • Early Career

NIH Funding · FY2024

Total Funding
$1.7M
Fiscal year 2024
Grants Awarded
4
Active NIH grants
National Rank
#7,385
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $1.7M across 4 grants · National rank #7385.

Top grants by award amount

Charles E. Chalfant's NIH grant portfolio, ranked by award amount.

  • 5R01AI139072-07R01
    The roles of ceramide and its derivatives in A. phagocytophilum pathogenesis
    $700.7K
    award amount
  • 5R01GM137394-05R01
    The role and mechanistic regulation of cPLA2alpha in eicosanoid biosynthesis and wound healing
    $454.7K
    award amount
  • 5R01DK126444-04R01
    iPLA2beta-mediated alternative splicing and beta-cell death in type 1 diabetes
    $452.5K
    award amount
  • 5P01CA171983-10P01
    Targeted Sphingolipid Metabolism for Treatment of AML
    $55.1K
    award amount

Affiliations

Institutions that have administered grants for Charles E. Chalfant.

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    University of Virginia
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #7385
  5. 2024
    Multi-Institutional Research
    Awards at 2 institutions